| Literature DB >> 8096186 |
P R Hutchings1, A Cooke, K Dawe, H Waldmann, I M Roitt.
Abstract
Treatment with a non-depleting monoclonal antibody to CD4 in the presence of mouse thyroglobulin (MTg) inhibits the development of murine autoimmune thyroiditis. This unresponsiveness was transferrable since such treatment generated a population of donor cells which could suppress the thyroiditis induced in lightly irradiated recipients by subsequent challenge with specific antigen. The suppression appears to be both antigen specific and antigen dependent and seems to discriminate between TH1 and TH2 helper subsets in that there is no significant effect on anti-MTg autoantibodies after challenge.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8096186 DOI: 10.1002/eji.1830230431
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532